Bristol-Myers Squibb logo

Bristol-Myers Squibb

Stock
Stock
ISIN: US1101221083
Ticker: BMY
US1101221083
BMY

Price

Price

Historical dividends and forecast

All dividend data

Bristol-Myers Squibb has so far distributed $2.40 in 2024. The next dividend will be paid on 01.02.2025


$1.193

CHART BY

Frequently asked questions

What is Bristol-Myers Squibb's market capitalization?

The market capitalization of Bristol-Myers Squibb is $117.39B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Bristol-Myers Squibb?

Bristol-Myers Squibb's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.597. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bristol-Myers Squibb's stock?

Currently, 25 analysts cover Bristol-Myers Squibb's stock, with a consensus target price of $53.15. Analyst ratings provide insights into the stock's expected performance.

What is Bristol-Myers Squibb's revenue over the trailing twelve months?

Over the trailing twelve months, Bristol-Myers Squibb reported a revenue of $47.44B.

What is the EBITDA for Bristol-Myers Squibb?

Bristol-Myers Squibb's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $21.31B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bristol-Myers Squibb?

Bristol-Myers Squibb has a free cash flow of $9.00B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Bristol-Myers Squibb's stock?

The 5-year beta for Bristol-Myers Squibb is 0.45. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Bristol-Myers Squibb have, and what sector and industry does it belong to?

Bristol-Myers Squibb employs approximately 34,100 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Bristol-Myers Squibb's shares?

The free float of Bristol-Myers Squibb is 2.03B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$117.39B

5Y beta

 
0.45

EPS (TTM)

 
-$3.597

Free Float

 
2.03B

Revenue (TTM)

 
$47.44B

EBITDA (TTM)

 
$21.31B

Free Cashflow (TTM)

 
$9.00B

Pricing

1D span
$57.54$58.53
52W span
$39.35$61.08

Analyst Ratings

The price target is $53.15 and the stock is covered by 25 analysts.

Buy

4

Hold

20

Sell

1

Information

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

34,100

Biotechnology & Drugs

Health Care

Identifier

ISIN

US1101221083

Primary Ticker

BMY

Knockouts

Join the conversation